Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Biodexa Receives US FDA Fast Track Designation for eRapa in
BIODEXA - Bioglass
Biodexa gets Orphan Drug Designation for eRapa in FAP | DataM ...
BIODEXA ® - BIO PHARMACHEMIE
BIODEXA 8MG/2ML SOL INY IV/IM X 2ML – Farmacia Velavida
Proud for our great achievement! Stay tuned for more!!! | Biodexa ...
BDRX Stock Overview: Comprehensive Insights on Biodexa Pharmaceuticals ...
Biodexa Pharmaceuticals PLC launches $5.0M direct offering | Biodexa ...
Compra acciones de Biodexa Pharmaceuticals plc ADS | Precio de $BDRX ...
In the News | Biodexa Pharmaceuticals
Buy Biodexa Pharmaceuticals Plc Stock – BDRX Stock Quote Today ...
BDRX - Biodexa Pharmaceuticals | Fundamentei
Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can ...
Biodexa Pharmaceuticals Stock Surges: What’s Next?
Biodexa Pharmaceuticals | Animo
Biodexa Pharmaceuticals’ Remarkable Stock Rise
Biodexa Pharmaceuticals (BDRX) Stock Analysis: $8.65 Target on Recent ...
We at Biodexa are excited to start up this pivotal Phase 3 study. We ...
Advancing Medicines for a Brighter Future | Biodexa
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa ...
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent ...
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer ...
Biodexa (BDRX) Advances eRapa Phase 3 Trial for FAP Treatment
Biodexa Advances eRapa to Phase 3 for FAP Following FDA Meeting, Shares ...
Biodexa Pharmaceuticals will rise 8,000% at the open
Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) - YouTube
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic ...
BDRX Stock - Biodexa Pharmaceuticals TOP gainers LOW float HEAVY volume ...
First patient recruited for Tolimidone study in T1D | Biodexa ...
Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled
Biodexa Launches Phase 3 Trial for First-Ever FAP Treatment, Eyes $7B ...
Our Mission is to Advance Medicines for Patients | About Biodexa
Biodexa Asset Offers Potential to ‘Radically Improve’ Treatment for ...
BDRX | Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug ...
Biodexa Pharmaceuticals activates first European Site for Phase 3 ...
Biodexa Pharmaceuticals (BDRX) Stock Price & Overview
Jual BIODEXA Inj 100 ml / OBAT ANTIRADANG HEWAN | Shopee Indonesia
Biodexa Shares Soar 128% on Positive Phase 2 Results in Rare Disease ...
Biodexa Pharmaceuticals PLC - AnnualReports.com
Biodexa Pharmaceuticals Stock Soaring: Time to Buy? - StocksToTrade
Biodexa Pharmaceuticals Aktie • A41E6F • US59564R8806 • onvista
Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents ...
Biodexa (Nasdaq: BDRX) Secures FDA Fast Track for eRapa in FAP, a Rare ...
Biodexa Prepares to Launch Phase 3 Trial for Rare Cancer Drug With Full ...
Biodexa Pharmaceuticals announces outcome of a Type C meeting with FDA ...
Biodexa Stocks Shine: Decoding the Surge
Biodexa Pharmaceuticals Begins Phase 3 Trial for FAP Treatment ...
Biodexa Pharmaceuticals' Stock Skyrockets! What's Happening ...
Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients ...
Biodexa Completes Treatment in Pediatric Glioma Treatment Study; Shares ...
Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
For Patients | Biodexa Pharmaceuticals
Preliminary Results for the Year Ended 31 December 2022 | Biodexa ...
Pipeline | Biodexa Pharmaceuticals
Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone ...
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through ...
Biodexa Stocks Shine: Decoding the Surge - StocksToTrade
Following Positive Phase 2 Results And Orphan Drug Designation, Biodexa ...
Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient ...
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare ...
BDRX Latest News and Headlines — TradingView
Biodex Dexametasona Injetável 10ml Biofarm - Aluren Soluções ...
Ladenburg Acts as Sole Placement Agent in the $5 Million Registered ...
Biodex Dexametasona+Tobramicina Solución Oftálmica X 5Ml Bioglass ...
BIODEX C/ 20 COMP DEXAMETASONA BIOFARM
Bula Biodex Comprimidos | PDF
Biodexa’s Revolutionary Step in Pharma
First Patient Dosed in Phase 2 Trial of Novel Oral Type 1 Diabetes ...
Biodexa's FAP Drug Receives FDA Fast Track Status Following Positive ...
Biodexa's eRapa Receives US FDA Fast Track Designation for Familial ...
BDRX Stock (Biodexa Pharmaceuticals stock analysis) BDRX STOCK ...
Biodexa's eRapa Shows 29% Polyp Reduction in FAP Trial, Advances Cancer ...
Pharma News | Biodexa, AbbVie, Insmed
PPT - Pharma Companies Stocks Overview PowerPoint Presentation, free ...
Biodexa’s 25% Surge: What’s Driving the Market?
Biodex 20 Comprimidos - Azul Pet
Vet Bio Remedies - Veterinary Medicines
BDRX Stock Soars: Time to Invest?
Is Biodexa’s Stock Surge Sustainable?
Biodexa's 40% Surge: A Biotech Breakthrough or Volatile Hype?
First two subjects enrolled in Biodexa’s trial for FAP treatment
Biodexa's 52% Surge: A Biotech Breakthrough or Volatile Hype?
EX-99.1 2 ex99_1.htm EXHIBIT 99.1
BDRX (Biodexa Pharmaceuticals plc) – Technical Charts and Market Data ...
英国临床阶段生物制药公司：Biodexa Pharmaceuticals Plc (BDRX) | 美股之家 - 港股美股开户投资百科全书
%202024%20copy.jpg)
